Provided by Tiger Trade Technology Pte. Ltd.

Monkeypox Concept

1,885.62
+46.512.53%
Number of Gainers:7
Number of Losers:3
Number of Flat:1
PE:- -
High:1,887.70
Open:1,839.21
Low:1,839.21
Close:1,839.11
Volume:77.74M
Turnover:1.30B
Market Cap:208.86B
Float Cap:207.97B

Loading ...

SM, Casey’s, Gilead, Dominion, Insulet Trending With Analysts

TIPRANKS
·
Yesterday

Does Medicine's New Obsession Really Work? -- Barron's

Dow Jones
·
Yesterday

Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Yesterday

Experimental treatments could help US Ebola patient

Reuters
·
Yesterday

Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Yesterday

Virax Biolabs announces extraordinary shareholder meeting

Reuters
·
Yesterday

FDA Grants Accelerated Approval to Gilead’s Hepcludex® (Bulevirtide-Gmod), the First and Only Approved Treatment for Chronic Hepatitis Delta Virus (Hdv)

THOMSON REUTERS
·
Yesterday

US FDA approves Gilead's drug for deadly liver infection

Reuters
·
Yesterday

FDA: Approved Hepcludex Injection to Treat Chronic Hepatitis Delta Virus Infection in Adults Without Cirrhosis or With Compensated Cirrhosis

THOMSON REUTERS
·
Yesterday

FACTBOX-Bundibugyo Ebola vaccines and treatments in development

Reuters
·
Yesterday

China's commerce ministry holds meeting with foreign pharmaceutical firms

Reuters
·
May 22

WHO raises risk of Ebola outbreak in Congo to 'very high' at national level

Reuters
·
May 22

BRIEF-Gilead Receives CHMP Positive Opinion For Trodelvy® In First-Line Metastatic Triple-Negative Breast Cancer

Reuters
·
May 22

Gilead receives positive CHMP opinion for Trodelvy in TNBC

TIPRANKS
·
May 22

Gilead Gets Positive Opinion From European Regulators on Breast-Cancer Treatment

Dow Jones
·
May 22

Gilead Trodelvy wins CHMP backing for first-line metastatic triple-negative breast cancer use

Reuters
·
May 22

Gilead Receives Chmp Positive Opinion for Trodelvy® in First-Line Metastatic Triple-Negative Breast Cancer for Patients Not Candidates for Pd-(L)1 Inhibitors

THOMSON REUTERS
·
May 22

Analysts Are Bullish on These Healthcare Stocks: Inovio Pharmaceuticals (INO), Vera Therapeutics (VERA)

TIPRANKS
·
May 22

Quest Diagnostics Shareholders Back Board, Pay and Auditor

TIPRANKS
·
May 22

Kite presents updated Phase 1 data for KITE-753 CAR-T in relapsed B-cell lymphoma

Reuters
·
May 22